Literature DB >> 17445639

Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones.

Sakip Erturhan1, Ahmet Erbagci, Faruk Yagci, Mehmet Celik, Mehmet Solakhan, Kemal Sarica.   

Abstract

OBJECTIVES: To evaluate the activity of the therapeutic agents (tamsulosin and/or tolterodine) used to accelerate the expulsion of stones and to reduce the probable complications during observation of the medical treatment of distal ureteral stones to allow spontaneous passage.
METHODS: A total of 120 patients with distal ureteral stones were included in the study. Patients with stones less than 10 mm and allowing urinary flow were included in the study. The patients were studied in four randomly divided groups. Group 1 patients received tamsulosin 0.4 mg/day, group 2 patients received tamsulosin 0.4 mg/day plus tolterodine 2 mg (twice a day), group 3 patients received tolterodine 2 mg (twice a day), and group 4 patients did not receive any medical treatment (control group).
RESULTS: Differences among the four groups in patient age and stone dimension were not statistically significant (P >0.05). The stone expulsion rates were greater (P <0.05) in groups 1 and 2 than in groups 3 and 4. A significant variation (P <0.05) regarding the time to stone expulsion was observed in groups 1 and 2.
CONCLUSIONS: In our study, the use of tamsulosin for the expulsion of distal ureteral stones was effective; however, the use of tolterodine provided no additional advantages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445639     DOI: 10.1016/j.urology.2007.01.009

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

1.  Effectiveness of doxazosin in the management of lower ureteral stones in male and female patients.

Authors:  Berkan Resorlu; Omer Faruk Bozkurt; Cagri Senocak; Ali Unsal
Journal:  Int Urol Nephrol       Date:  2010-11-12       Impact factor: 2.370

Review 2.  Medical expulsive therapy for distal ureteral stones.

Authors:  Vassilios Tzortzis; Charalampos Mamoulakis; Jorge Rioja; Stavros Gravas; Martin C Michel; Jean J M C H de la Rosette
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  Can alpha blockers facilitate the placement of ureteral access sheaths in retrograde intrarenal surgery?

Authors:  Sakıp Erturhan; Ömer Bayrak; Haluk Şen; Ali Erdem Yılmaz; İlker Seçkiner
Journal:  Turk J Urol       Date:  2019-01-22

4.  Efficacy of tolterodine for medical treatment of intramural ureteral stone with vesical irritability.

Authors:  Jian Lin Lv; Qin Nai Tang; Ju Hong Hui; Fa De Lu
Journal:  Urol Res       Date:  2010-11-11

5.  Management of ureteral calculi and medical expulsive therapy in emergency departments.

Authors:  Stefano C M Picozzi; Carlo Marenghi; Stefano Casellato; Cristian Ricci; Maddalena Gaeta; Luca Carmignani
Journal:  J Emerg Trauma Shock       Date:  2011-01

6.  Tamsulosin and tolterodine in the medical expulsive therapy for intramural ureteral stones with vesical irritability: a prospective randomized study.

Authors:  Jian Lin Lv; Qing lai Tang
Journal:  Urolithiasis       Date:  2013-08-21       Impact factor: 3.436

7.  Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study.

Authors:  Jian Lin Lu; Qing Lai Tang; Fa De Liu; Ju Hong Hui
Journal:  Urol Res       Date:  2012-08-25

Review 8.  Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Use of tamsulosin in patients with urinary calculi to increase spontaneous stone passage.

Authors:  Brook Woolley
Journal:  Emerg Med J       Date:  2007-10       Impact factor: 2.740

Review 9.  Medical therapy of stone disease: from prevention to promotion of passage options.

Authors:  Michael Lipkin; Ojas Shah
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

Review 10.  Alpha-blockers as medical expulsive therapy for ureteral stones.

Authors:  Thijs Campschroer; Xiaoye Zhu; Robin Wm Vernooij; Mtw Tycho Lock
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.